Hypothermic oxygenated machine perfusion for extended criteria donor allografts: Preliminary experience with extended organ preservation times in the setting of organ reallocation
Background In times of critical organ shortage, poor organ pool utilization and increased use of extended‐criteria donor (ECD) allografts remain a major problem. Hypothermic oxygenated machine perfusion (HOPE) has emerged as a promising and feasible strategy in ECD liver transplantation (LT). Howeve...
Gespeichert in:
Veröffentlicht in: | Artificial organs 2022-02, Vol.46 (2), p.306-311 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 311 |
---|---|
container_issue | 2 |
container_start_page | 306 |
container_title | Artificial organs |
container_volume | 46 |
creator | Pavicevic, Sandra Uluk, Deniz Reichelt, Sophie Fikatas, Panagiotis Globke, Brigitta Raschzok, Nathanael Schmelzle, Moritz Öllinger, Robert Schöning, Wenzel Eurich, Dennis Pratschke, Johann Lurje, Georg |
description | Background
In times of critical organ shortage, poor organ pool utilization and increased use of extended‐criteria donor (ECD) allografts remain a major problem. Hypothermic oxygenated machine perfusion (HOPE) has emerged as a promising and feasible strategy in ECD liver transplantation (LT). However, potential safety limits regarding the duration of perfusion are yet to be explored. Besides marginal allograft quality (steatosis), prolonged cold ischemia time remains the most important factor for a high number of liver allografts being declined for transplantation.
Patients and Methods
Two ECD‐allografts were each allocated to two recipients, who proved to be unsuitable to receive the assigned allograft upon arrival at the transplant center. The organs were reallocated by Eurotransplant and accepted by our center for two different backup patients. During that time, HOPE was commenced and continued until the recipient hepatectomy was completed. Postoperative allograft function was assessed by serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, and International Normalized Ratio. Incidence of early allograft dysfunction (EAD), postoperative complications, and length of hospital stay were analyzed.
Results
HOPE was applied for 4 h 35 min and 4 h 20 min, resulting in a total cold preservation time of 17 h 29 min and 15 h 20 min, respectively. Both recipients displayed decreasing serum transaminases and bilirubin levels postoperatively. No EAD or major postoperative complications occurred in either patient. Serum ALT and AST levels were within the normal range at discharge.
Conclusions
Extended HOPE enables the safe extension of preservation time for up to 18 h in human LT. End‐ischemic HOPE may significantly improve organ pool utilization, while simultaneously facilitating operating room logistics and preventing organ injury.
Despite severe organ shortage, a relevant number of allografts is being declined because of marginal quality and prolonged cold ischemia time. Due to organ reallocation and operating room logistics, two extended‐criteria donor allografts were subjected to hypothermic oxygenated machine perfusion (HOPE), resulting in total cold preservation time of up to 18 h. No major complications or early allograft dysfunction occurred in either allograft. Extended HOPE might significantly improve organ pool utilization and facilitate operating room logistics. |
doi_str_mv | 10.1111/aor.14103 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2592316884</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2618466133</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4283-91f551c1894288718f1461d6a4bed38cd483ff755f2eca2386357516880d52863</originalsourceid><addsrcrecordid>eNp1kd9qFDEUh4Modq1e-AIS8EYvps3_yXhXilqhUBEF74Y0c7KbMpOMSabtPpcvaLa7KgjmJjnJd76E_BB6SckJrePUxHRCBSX8EVpRyWRDZSceoxWhijRSie9H6FnON4SQVhD1FB1x0TLBeLdCPy-2cywbSJO3ON5v1xBMgQFPxm58ADxDckv2MWAXE4b7AmGoxzb5AskbPMRQ9804xnUyruR3-HOC0U8-mLStfO33ECzgO182f_tjWpuA5wQZ0q0pO3_xE2Ts62IDOEMpPqxxdAc0we4O-4A-R0-cGTO8OMzH6NuH91_PL5rLq4-fzs8uGyuY5k1HnZTUUt3VUrdUOyoUHZQR1zBwbQehuXOtlI6BNYxrxWUrqdKaDJLV6hi92XvnFH8skEs_-WxhHE2AuOSeyY7xHS8q-vof9CYuKdTX9UxRLZSinFfq7Z6yKeacwPVz8lP9qJ6SfpdkX5PsH5Ks7KuDcbmeYPhD_o6uAqd74M6PsP2_qT-7-rJX_gLLhat2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2618466133</pqid></control><display><type>article</type><title>Hypothermic oxygenated machine perfusion for extended criteria donor allografts: Preliminary experience with extended organ preservation times in the setting of organ reallocation</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Pavicevic, Sandra ; Uluk, Deniz ; Reichelt, Sophie ; Fikatas, Panagiotis ; Globke, Brigitta ; Raschzok, Nathanael ; Schmelzle, Moritz ; Öllinger, Robert ; Schöning, Wenzel ; Eurich, Dennis ; Pratschke, Johann ; Lurje, Georg</creator><creatorcontrib>Pavicevic, Sandra ; Uluk, Deniz ; Reichelt, Sophie ; Fikatas, Panagiotis ; Globke, Brigitta ; Raschzok, Nathanael ; Schmelzle, Moritz ; Öllinger, Robert ; Schöning, Wenzel ; Eurich, Dennis ; Pratschke, Johann ; Lurje, Georg</creatorcontrib><description>Background
In times of critical organ shortage, poor organ pool utilization and increased use of extended‐criteria donor (ECD) allografts remain a major problem. Hypothermic oxygenated machine perfusion (HOPE) has emerged as a promising and feasible strategy in ECD liver transplantation (LT). However, potential safety limits regarding the duration of perfusion are yet to be explored. Besides marginal allograft quality (steatosis), prolonged cold ischemia time remains the most important factor for a high number of liver allografts being declined for transplantation.
Patients and Methods
Two ECD‐allografts were each allocated to two recipients, who proved to be unsuitable to receive the assigned allograft upon arrival at the transplant center. The organs were reallocated by Eurotransplant and accepted by our center for two different backup patients. During that time, HOPE was commenced and continued until the recipient hepatectomy was completed. Postoperative allograft function was assessed by serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, and International Normalized Ratio. Incidence of early allograft dysfunction (EAD), postoperative complications, and length of hospital stay were analyzed.
Results
HOPE was applied for 4 h 35 min and 4 h 20 min, resulting in a total cold preservation time of 17 h 29 min and 15 h 20 min, respectively. Both recipients displayed decreasing serum transaminases and bilirubin levels postoperatively. No EAD or major postoperative complications occurred in either patient. Serum ALT and AST levels were within the normal range at discharge.
Conclusions
Extended HOPE enables the safe extension of preservation time for up to 18 h in human LT. End‐ischemic HOPE may significantly improve organ pool utilization, while simultaneously facilitating operating room logistics and preventing organ injury.
Despite severe organ shortage, a relevant number of allografts is being declined because of marginal quality and prolonged cold ischemia time. Due to organ reallocation and operating room logistics, two extended‐criteria donor allografts were subjected to hypothermic oxygenated machine perfusion (HOPE), resulting in total cold preservation time of up to 18 h. No major complications or early allograft dysfunction occurred in either allograft. Extended HOPE might significantly improve organ pool utilization and facilitate operating room logistics.</description><identifier>ISSN: 0160-564X</identifier><identifier>EISSN: 1525-1594</identifier><identifier>DOI: 10.1111/aor.14103</identifier><identifier>PMID: 34724239</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Aged ; Alanine ; Alanine transaminase ; Alanine Transaminase - blood ; Allografts ; Aspartate aminotransferase ; Aspartate Aminotransferases - blood ; Bilirubin ; Bilirubin - blood ; Cold Ischemia ; Complications ; Criteria ; Cryopreservation ; donation after brain death ; extended criteria donor ; extended preservation time ; Female ; Hepatectomy ; Humans ; hypothermic oxygenated machine perfusion ; Injury prevention ; Ischemia ; Liver ; Liver transplantation ; Liver Transplantation - methods ; Liver transplants ; Logistics ; Male ; Middle Aged ; operating room logistics ; Organ Preservation - methods ; Oxygenation ; Patients ; Perfusion ; Perfusion - methods ; Postoperative ; Serum levels ; Steatosis ; Time Factors ; Transaminases ; Transplantation ; Transplants & implants</subject><ispartof>Artificial organs, 2022-02, Vol.46 (2), p.306-311</ispartof><rights>2021 The Authors. published by International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC</rights><rights>2021 The Authors. Artificial Organs published by International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.</rights><rights>2021. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4283-91f551c1894288718f1461d6a4bed38cd483ff755f2eca2386357516880d52863</citedby><cites>FETCH-LOGICAL-c4283-91f551c1894288718f1461d6a4bed38cd483ff755f2eca2386357516880d52863</cites><orcidid>0000-0001-9674-0756</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Faor.14103$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Faor.14103$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34724239$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pavicevic, Sandra</creatorcontrib><creatorcontrib>Uluk, Deniz</creatorcontrib><creatorcontrib>Reichelt, Sophie</creatorcontrib><creatorcontrib>Fikatas, Panagiotis</creatorcontrib><creatorcontrib>Globke, Brigitta</creatorcontrib><creatorcontrib>Raschzok, Nathanael</creatorcontrib><creatorcontrib>Schmelzle, Moritz</creatorcontrib><creatorcontrib>Öllinger, Robert</creatorcontrib><creatorcontrib>Schöning, Wenzel</creatorcontrib><creatorcontrib>Eurich, Dennis</creatorcontrib><creatorcontrib>Pratschke, Johann</creatorcontrib><creatorcontrib>Lurje, Georg</creatorcontrib><title>Hypothermic oxygenated machine perfusion for extended criteria donor allografts: Preliminary experience with extended organ preservation times in the setting of organ reallocation</title><title>Artificial organs</title><addtitle>Artif Organs</addtitle><description>Background
In times of critical organ shortage, poor organ pool utilization and increased use of extended‐criteria donor (ECD) allografts remain a major problem. Hypothermic oxygenated machine perfusion (HOPE) has emerged as a promising and feasible strategy in ECD liver transplantation (LT). However, potential safety limits regarding the duration of perfusion are yet to be explored. Besides marginal allograft quality (steatosis), prolonged cold ischemia time remains the most important factor for a high number of liver allografts being declined for transplantation.
Patients and Methods
Two ECD‐allografts were each allocated to two recipients, who proved to be unsuitable to receive the assigned allograft upon arrival at the transplant center. The organs were reallocated by Eurotransplant and accepted by our center for two different backup patients. During that time, HOPE was commenced and continued until the recipient hepatectomy was completed. Postoperative allograft function was assessed by serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, and International Normalized Ratio. Incidence of early allograft dysfunction (EAD), postoperative complications, and length of hospital stay were analyzed.
Results
HOPE was applied for 4 h 35 min and 4 h 20 min, resulting in a total cold preservation time of 17 h 29 min and 15 h 20 min, respectively. Both recipients displayed decreasing serum transaminases and bilirubin levels postoperatively. No EAD or major postoperative complications occurred in either patient. Serum ALT and AST levels were within the normal range at discharge.
Conclusions
Extended HOPE enables the safe extension of preservation time for up to 18 h in human LT. End‐ischemic HOPE may significantly improve organ pool utilization, while simultaneously facilitating operating room logistics and preventing organ injury.
Despite severe organ shortage, a relevant number of allografts is being declined because of marginal quality and prolonged cold ischemia time. Due to organ reallocation and operating room logistics, two extended‐criteria donor allografts were subjected to hypothermic oxygenated machine perfusion (HOPE), resulting in total cold preservation time of up to 18 h. No major complications or early allograft dysfunction occurred in either allograft. Extended HOPE might significantly improve organ pool utilization and facilitate operating room logistics.</description><subject>Aged</subject><subject>Alanine</subject><subject>Alanine transaminase</subject><subject>Alanine Transaminase - blood</subject><subject>Allografts</subject><subject>Aspartate aminotransferase</subject><subject>Aspartate Aminotransferases - blood</subject><subject>Bilirubin</subject><subject>Bilirubin - blood</subject><subject>Cold Ischemia</subject><subject>Complications</subject><subject>Criteria</subject><subject>Cryopreservation</subject><subject>donation after brain death</subject><subject>extended criteria donor</subject><subject>extended preservation time</subject><subject>Female</subject><subject>Hepatectomy</subject><subject>Humans</subject><subject>hypothermic oxygenated machine perfusion</subject><subject>Injury prevention</subject><subject>Ischemia</subject><subject>Liver</subject><subject>Liver transplantation</subject><subject>Liver Transplantation - methods</subject><subject>Liver transplants</subject><subject>Logistics</subject><subject>Male</subject><subject>Middle Aged</subject><subject>operating room logistics</subject><subject>Organ Preservation - methods</subject><subject>Oxygenation</subject><subject>Patients</subject><subject>Perfusion</subject><subject>Perfusion - methods</subject><subject>Postoperative</subject><subject>Serum levels</subject><subject>Steatosis</subject><subject>Time Factors</subject><subject>Transaminases</subject><subject>Transplantation</subject><subject>Transplants & implants</subject><issn>0160-564X</issn><issn>1525-1594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp1kd9qFDEUh4Modq1e-AIS8EYvps3_yXhXilqhUBEF74Y0c7KbMpOMSabtPpcvaLa7KgjmJjnJd76E_BB6SckJrePUxHRCBSX8EVpRyWRDZSceoxWhijRSie9H6FnON4SQVhD1FB1x0TLBeLdCPy-2cywbSJO3ON5v1xBMgQFPxm58ADxDckv2MWAXE4b7AmGoxzb5AskbPMRQ9804xnUyruR3-HOC0U8-mLStfO33ECzgO182f_tjWpuA5wQZ0q0pO3_xE2Ts62IDOEMpPqxxdAc0we4O-4A-R0-cGTO8OMzH6NuH91_PL5rLq4-fzs8uGyuY5k1HnZTUUt3VUrdUOyoUHZQR1zBwbQehuXOtlI6BNYxrxWUrqdKaDJLV6hi92XvnFH8skEs_-WxhHE2AuOSeyY7xHS8q-vof9CYuKdTX9UxRLZSinFfq7Z6yKeacwPVz8lP9qJ6SfpdkX5PsH5Ks7KuDcbmeYPhD_o6uAqd74M6PsP2_qT-7-rJX_gLLhat2</recordid><startdate>202202</startdate><enddate>202202</enddate><creator>Pavicevic, Sandra</creator><creator>Uluk, Deniz</creator><creator>Reichelt, Sophie</creator><creator>Fikatas, Panagiotis</creator><creator>Globke, Brigitta</creator><creator>Raschzok, Nathanael</creator><creator>Schmelzle, Moritz</creator><creator>Öllinger, Robert</creator><creator>Schöning, Wenzel</creator><creator>Eurich, Dennis</creator><creator>Pratschke, Johann</creator><creator>Lurje, Georg</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9674-0756</orcidid></search><sort><creationdate>202202</creationdate><title>Hypothermic oxygenated machine perfusion for extended criteria donor allografts: Preliminary experience with extended organ preservation times in the setting of organ reallocation</title><author>Pavicevic, Sandra ; Uluk, Deniz ; Reichelt, Sophie ; Fikatas, Panagiotis ; Globke, Brigitta ; Raschzok, Nathanael ; Schmelzle, Moritz ; Öllinger, Robert ; Schöning, Wenzel ; Eurich, Dennis ; Pratschke, Johann ; Lurje, Georg</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4283-91f551c1894288718f1461d6a4bed38cd483ff755f2eca2386357516880d52863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aged</topic><topic>Alanine</topic><topic>Alanine transaminase</topic><topic>Alanine Transaminase - blood</topic><topic>Allografts</topic><topic>Aspartate aminotransferase</topic><topic>Aspartate Aminotransferases - blood</topic><topic>Bilirubin</topic><topic>Bilirubin - blood</topic><topic>Cold Ischemia</topic><topic>Complications</topic><topic>Criteria</topic><topic>Cryopreservation</topic><topic>donation after brain death</topic><topic>extended criteria donor</topic><topic>extended preservation time</topic><topic>Female</topic><topic>Hepatectomy</topic><topic>Humans</topic><topic>hypothermic oxygenated machine perfusion</topic><topic>Injury prevention</topic><topic>Ischemia</topic><topic>Liver</topic><topic>Liver transplantation</topic><topic>Liver Transplantation - methods</topic><topic>Liver transplants</topic><topic>Logistics</topic><topic>Male</topic><topic>Middle Aged</topic><topic>operating room logistics</topic><topic>Organ Preservation - methods</topic><topic>Oxygenation</topic><topic>Patients</topic><topic>Perfusion</topic><topic>Perfusion - methods</topic><topic>Postoperative</topic><topic>Serum levels</topic><topic>Steatosis</topic><topic>Time Factors</topic><topic>Transaminases</topic><topic>Transplantation</topic><topic>Transplants & implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pavicevic, Sandra</creatorcontrib><creatorcontrib>Uluk, Deniz</creatorcontrib><creatorcontrib>Reichelt, Sophie</creatorcontrib><creatorcontrib>Fikatas, Panagiotis</creatorcontrib><creatorcontrib>Globke, Brigitta</creatorcontrib><creatorcontrib>Raschzok, Nathanael</creatorcontrib><creatorcontrib>Schmelzle, Moritz</creatorcontrib><creatorcontrib>Öllinger, Robert</creatorcontrib><creatorcontrib>Schöning, Wenzel</creatorcontrib><creatorcontrib>Eurich, Dennis</creatorcontrib><creatorcontrib>Pratschke, Johann</creatorcontrib><creatorcontrib>Lurje, Georg</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Artificial organs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pavicevic, Sandra</au><au>Uluk, Deniz</au><au>Reichelt, Sophie</au><au>Fikatas, Panagiotis</au><au>Globke, Brigitta</au><au>Raschzok, Nathanael</au><au>Schmelzle, Moritz</au><au>Öllinger, Robert</au><au>Schöning, Wenzel</au><au>Eurich, Dennis</au><au>Pratschke, Johann</au><au>Lurje, Georg</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypothermic oxygenated machine perfusion for extended criteria donor allografts: Preliminary experience with extended organ preservation times in the setting of organ reallocation</atitle><jtitle>Artificial organs</jtitle><addtitle>Artif Organs</addtitle><date>2022-02</date><risdate>2022</risdate><volume>46</volume><issue>2</issue><spage>306</spage><epage>311</epage><pages>306-311</pages><issn>0160-564X</issn><eissn>1525-1594</eissn><abstract>Background
In times of critical organ shortage, poor organ pool utilization and increased use of extended‐criteria donor (ECD) allografts remain a major problem. Hypothermic oxygenated machine perfusion (HOPE) has emerged as a promising and feasible strategy in ECD liver transplantation (LT). However, potential safety limits regarding the duration of perfusion are yet to be explored. Besides marginal allograft quality (steatosis), prolonged cold ischemia time remains the most important factor for a high number of liver allografts being declined for transplantation.
Patients and Methods
Two ECD‐allografts were each allocated to two recipients, who proved to be unsuitable to receive the assigned allograft upon arrival at the transplant center. The organs were reallocated by Eurotransplant and accepted by our center for two different backup patients. During that time, HOPE was commenced and continued until the recipient hepatectomy was completed. Postoperative allograft function was assessed by serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, and International Normalized Ratio. Incidence of early allograft dysfunction (EAD), postoperative complications, and length of hospital stay were analyzed.
Results
HOPE was applied for 4 h 35 min and 4 h 20 min, resulting in a total cold preservation time of 17 h 29 min and 15 h 20 min, respectively. Both recipients displayed decreasing serum transaminases and bilirubin levels postoperatively. No EAD or major postoperative complications occurred in either patient. Serum ALT and AST levels were within the normal range at discharge.
Conclusions
Extended HOPE enables the safe extension of preservation time for up to 18 h in human LT. End‐ischemic HOPE may significantly improve organ pool utilization, while simultaneously facilitating operating room logistics and preventing organ injury.
Despite severe organ shortage, a relevant number of allografts is being declined because of marginal quality and prolonged cold ischemia time. Due to organ reallocation and operating room logistics, two extended‐criteria donor allografts were subjected to hypothermic oxygenated machine perfusion (HOPE), resulting in total cold preservation time of up to 18 h. No major complications or early allograft dysfunction occurred in either allograft. Extended HOPE might significantly improve organ pool utilization and facilitate operating room logistics.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34724239</pmid><doi>10.1111/aor.14103</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-9674-0756</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0160-564X |
ispartof | Artificial organs, 2022-02, Vol.46 (2), p.306-311 |
issn | 0160-564X 1525-1594 |
language | eng |
recordid | cdi_proquest_miscellaneous_2592316884 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Aged Alanine Alanine transaminase Alanine Transaminase - blood Allografts Aspartate aminotransferase Aspartate Aminotransferases - blood Bilirubin Bilirubin - blood Cold Ischemia Complications Criteria Cryopreservation donation after brain death extended criteria donor extended preservation time Female Hepatectomy Humans hypothermic oxygenated machine perfusion Injury prevention Ischemia Liver Liver transplantation Liver Transplantation - methods Liver transplants Logistics Male Middle Aged operating room logistics Organ Preservation - methods Oxygenation Patients Perfusion Perfusion - methods Postoperative Serum levels Steatosis Time Factors Transaminases Transplantation Transplants & implants |
title | Hypothermic oxygenated machine perfusion for extended criteria donor allografts: Preliminary experience with extended organ preservation times in the setting of organ reallocation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T06%3A42%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypothermic%20oxygenated%20machine%20perfusion%20for%20extended%20criteria%20donor%20allografts:%20Preliminary%20experience%20with%20extended%20organ%20preservation%20times%20in%20the%20setting%20of%20organ%20reallocation&rft.jtitle=Artificial%20organs&rft.au=Pavicevic,%20Sandra&rft.date=2022-02&rft.volume=46&rft.issue=2&rft.spage=306&rft.epage=311&rft.pages=306-311&rft.issn=0160-564X&rft.eissn=1525-1594&rft_id=info:doi/10.1111/aor.14103&rft_dat=%3Cproquest_cross%3E2618466133%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2618466133&rft_id=info:pmid/34724239&rfr_iscdi=true |